21.12.2022 07:15, João Guerra
Fundraising data reveals which Swiss and European venture capital investment firms have closed a new fund this year—and therefore have the money to invest in Swiss startups with a competitive edge.
A record
CHF 3.4 billion in venture capital flowed into Swiss startups between January and September 2022. But in the last months, startup investors have become more cautious due to Russia's invasion of Ukraine, rising inflation, and poor public market performance. Nevertheless, European venture capital funds are sitting on record levels of dry powder to invest in startups. Atomico’s State of European Tech report reports $85 billion for 2022.
We took a closer look at
our fundraising data to determine which Swiss and European venture capital investment firms have closed a new fund this year—and therefore have the money to invest in top Swiss startups with a scalable business model, a strong and diverse team to execute the vision, and a competitive edge.
New Swiss venture capital firms that have closed a new fund
BackBone Ventures |
ICT |
BiomedVC |
Biotech |
Blue Horizon Ventures |
Foodtech |
btov |
ICT |
DAA Capital Partners |
Deeptech |
Efficient Frontier Investing |
Medtech, Biotech, Deeptech, ICT |
Endeavour Vision |
Medtech |
EquityPitcher Ventures |
ICT |
F10 |
Fintech |
FiveT Fintech |
Fintech |
Forestay Capital |
ICT |
Helsana HealthInvest |
Medtech |
Hemex |
Life Sciences |
Kick Fund |
Deeptech |
Korify Ventures |
Medtech |
L1 Digital |
Fintech |
Lightbird Ventures AG |
ICT |
Maximon |
Medtech |
MRB Fund Partners |
Deeptech |
MTIP |
Medtech |
Nextech Invest |
Biotech |
Planven Entrepreneur Ventures |
ICT |
Privilège ventures |
Medtech, Deeptech, ICT |
Redalpine Venture Partners |
ICT, Fintech, Healthtech |
Serpentine Ventures |
Medtech, Deeptech, ICT |
Session.vc |
ICT |
SNGLR Capital |
Smart Cities |
Spicehouse Partners |
ICT |
Swiss Diabetes Venture Fund |
Life Sciences |
Swisscanto Invest |
Cleantech |
Swisscom Ventures |
ICT, Deeptech |
TX Ventures |
Fintech |
Versant Ventures |
Biotech |
Verve Capital Partners |
ICT |
VI Partners |
ICT, Life Sciences |
Wingman |
ICT |
20 European Venture Capital firms with the largest raised funds (400 million and plus)
Index Ventures
|
UK
|
SaaS, Fintech, Cleantech, ICT
|
Bain Capital
|
UK
|
General
|
Eurazeo
|
France
|
General
|
EQT Ventures
|
Sweden, UK, Germany
|
General
|
Partech
|
France
|
General
|
Anthemis
|
UK
|
Fintech
|
Balderton Capital
|
UK
|
General
|
Accel
|
UK
|
General
|
GRO Capital
|
Denmark
|
SaaS
|
SE Ventures
|
France
|
General
|
Quadrille Capital
|
France
|
Deeptech, Health
|
Creandum
|
Sweden
|
General
|
SpeedInvest
|
Austria
|
Deeptech, Fintech, Medtech, Industrial Tech, SaaS
|
Sofinnova Partners
|
France
|
Medtech
|
Eight Roads Ventures
|
UK
|
Deeptech, Fintech, Medtech, Industrial Tech, SaaS
|
Blossom Capital
|
UK
|
Fintech, SaaS, ICT
|
HV Capital
|
Germany
|
General
|
468 Capital
|
Germany
|
ICT
|
Cusp Capital
|
Germany
|
ICT
|
Orange Ventures
|
France
|
ICT, Fintech
|
Yes, these venture capital funds have a lot of dry powder; but be aware that they will adapt their investment strategy. "Capital will still flow into strong early-stage startups as Switzerland has great tech universities that continuously generate valuable startup ideas," said Stefan Steiner, Co-Managing Director at Venturelab. "Growth startups will need to show strong traction to convince investors and valuations will come down again to a more sustainable level."
Startups should therefore prepare for a longer fundraising period than in previous years and should keep their burn rate low to extend their run rate. Read more in our article on
Venture Capital predictions for 2023 about the investor outlook and trends for the upcoming year.
Are any funds missing from our list? Get in touch and let us know.